Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Norion Bank AB | NORION | Nov 25, 2024 | 37.75 | -3.21 |
Northbaze Group | NBZ | Nov 25, 2024 | 0.15 | -30.56 |
Northern CapSek Ventures | CAPS | Nov 25, 2024 | 0.17 | +1.54 |
Northern CapSek Ventures PREF | CAPSPREF | Nov 25, 2024 | 0.43 | 0.00 |
Northgold | NG | Nov 25, 2024 | 0.69 | +2.96 |
Norva24 | NORVA | Nov 25, 2024 | 27.20 | -0.18 |
Nosa Plugs | NOSA | Nov 25, 2024 | 0.64 | +4.96 |
Nosium | NOSIUMB | Nov 25, 2024 | 7.96 | +4.19 |
Note | NOTE | Nov 25, 2024 | 131.20 | +3.06 |
Novotek B | NTEKB | Nov 25, 2024 | 67.00 | 0.00 |
Novus Group | NOVU | Nov 25, 2024 | 3.06 | -7.27 |
Nowonomics | NOWO | Nov 25, 2024 | 3.36 | +5.00 |
NP3 Fastigheter | NP3 | Nov 25, 2024 | 250.50 | +1.62 |
NP3 Fastigheter Pref | NP3PREF | Nov 25, 2024 | 30.25 | +0.50 |
NYAB | NYAB | Nov 25, 2024 | 5.39 | 0.00 |
Nyfosa | NYF | Nov 25, 2024 | 103.50 | +0.49 |
Obducat B | OBDUB | Nov 25, 2024 | 1.05 | -1.40 |
Observit | OBSE | Nov 25, 2024 | 0.46 | 0.00 |
ODI Pharma | ODI | Nov 25, 2024 | 2.90 | -9.38 |
Odinwell | ODIN | Nov 25, 2024 | 2.86 | +2.88 |
OEM International B | OEMB | Nov 25, 2024 | 117.80 | -0.51 |
Ogunsen B | OGUNB | Nov 25, 2024 | 31.45 | +0.48 |
OMX GES OMXS30 Ethical Price Index | OMXS30ETHIC | Nov 25, 2024 | 301.40 | -0.03 |
OMX NORDIC 40 | OMXN40 | Nov 25, 2024 | 2 609.69 | -0.22 |
OMX Oslo 20 GI | OMXO20GI | Nov 25, 2024 | 1 338.38 | +0.11 |
OMX Oslo 20 PI | OMXO20PI | Nov 25, 2024 | 738.71 | +0.11 |
OMX Stockholm 30 | OMXS30 | Nov 25, 2024 | 2 512.45 | -0.07 |
OMX Stockholm 30 GI | OMXS30GI | Nov 25, 2024 | 493.23 | -0.07 |
OMX Stockholm 60 Cap PI | OMXS60CAP | Nov 25, 2024 | 310.18 | +0.23 |
OMX Stockholm 60 PI | OMXS60PI | Nov 25, 2024 | 291.39 | +0.20 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.